BioView

medical devices

About

BioView is a medical technology company based in Israel, founded in 2000, with a subsidiary in the United States focused on sales and support. The company specializes in developing and marketing automated cell imaging and analysis solutions for cytology, cytogenetics, pathology, and clinical laboratories worldwide. BioView's core products include advanced imaging and analysis platforms that automate the operation of fully motorized microscopes. Key offerings are the Accord and Accord Plus systems for real-time FISH sample analysis, the Allegro Plus for identifying chromosomal abnormalities, and the DUET Imaging and Analysis Platform, which is FDA-cleared for cancer detection applications. The DeNovo System facilitates the detection of circulating tumor cells, while the NGK platform enhances karyotyping efficiency using deep learning technology. The company serves clinical and research laboratories globally, providing tools that streamline workflows and improve diagnostic accuracy. BioView is also developing a noninvasive early detection test for lung cancer, furthering its commitment to enhancing cancer detection capabilities.

Technologies

Outlook Remote Circle

Keywords

fish analysis circulating tumor cells detection digital pathology karyotyping target fish alk fish ros1 fish cll fish her2neu fish fish web analysis ai based image analysis cloud applications liquid biopsy rare cells medical equipment manufacturing medical equipment and supplies manufacturing automated imaging regulatory approvals noninvasive lung cancer detection clinical laboratory solutions biomarker analysis cytology medical devices fda clearance image analysis algorithms b2b laboratory workflow automation high-resolution cameras multiplex fish assay automated cell imaging

Location

44 Manning Rd, Billerica, Massachusetts, United States, 01821

Related Companies

Companies in the same industry